QCM
GILD icon

QRG Capital Management’s Gilead Sciences GILD Stock Holding History

QRG Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7M Buy
227,523
+1,277
+0.6% +$168K 0.24% 75
2026
Q1 		$31.5M Sell
226,246
-15,139
-6% -$2.12M 0.33% 55
2025
Q4 		$29.6M Buy
241,385
+14,133
+6% +$1.72M 0.33% 53
2025
Q3 		$25.2M Sell
227,252
-72,335
-24% -$8.22M 0.31% 61
2025
Q2 		$33.2M Buy
299,587
+19,277
+7% +$2.05M 0.29% 74
2025
Q1 		$31.4M Buy
280,310
+21,725
+8% +$2.24M 0.33% 69
2024
Q4 		$23.9M Buy
258,585
+17,141
+7% +$1.54M 0.25% 81
2024
Q3 		$20.2M Sell
241,444
-11,865
-5% -$905K 0.22% 104
2024
Q2 		$17.4M Sell
253,309
-125,970
-33% -$8.41M 0.21% 109
2024
Q1 		$27.8M Sell
379,279
-22,693
-6% -$1.75M 0.35% 61
2023
Q4 		$32.6M Buy
401,972
+100,490
+33% +$7.82M 0.48% 40
2023
Q3 		$22.6M Buy
+301,482
New +$23.2M 0.39% 60

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QRG Capital Management's GILD Position: Q2 2026 in Review

QRG Capital Management increased its Gilead Sciences (GILD) stake by 0.56% in Q2 2026, buying an estimated $168K and bringing the position to 227,523 shares worth $28.7M. The position accounts for 0.24% of the portfolio, ranked #75.

QRG Capital Management first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $33.2M in Q2 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • QRG Capital Management held 227,523 shares of Gilead Sciences worth $28.7M as of Q2 2026.
  • QRG Capital Management bought 1,277 Gilead Sciences shares in Q2 2026, an estimated $168K.
  • Gilead Sciences made up 0.24% of QRG Capital Management's portfolio in Q2 2026, its #75 holding.
  • QRG Capital Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Gilead Sciences position peaked at $33.2M in Q2 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.